UB23:LSE:LSE-UBS MSCI Canada UCITS CAD A-dis (GBX)

ETF | Others |

Last Closing

USD 3665.5

Change

+17.00 (+0.47)%

Market Cap

N/A

Volume

1.42K

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

-2.50 (-1.12%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

-2.23 (-1.57%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.03 (+0.24%)

USD 581.04B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

-0.17 (-0.96%)

USD 581.04B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

+1.15 (+1.88%)

USD 266.08B
0QZO:LSE 0QZO

-3.00 (-2.67%)

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

-0.29 (-0.97%)

USD 239.13B
0QZ3:LSE Qualcomm Inc.

-4.61 (-2.83%)

USD 202.26B
0R24:LSE Intel Corp.

-0.36 (-1.78%)

USD 196.14B

ETFs Containing UB23:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.55% 89% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.55% 89% A- 82% B
Trailing 12 Months  
Capital Gain 14.80% 69% C- 70% C-
Dividend Return 0.02% 14% F 14% F
Total Return 14.82% 67% D+ 68% D+
Trailing 5 Years  
Capital Gain 41.31% 66% D+ 73% C
Dividend Return 0.12% 18% F 29% F
Total Return 41.43% 63% D 71% C-
Average Annual (5 Year Horizon)  
Capital Gain 9.86% 62% D 66% D+
Dividend Return 9.86% 61% D- 65% D
Total Return 0.00% 10% F 7% C-
Risk Return Profile  
Volatility (Standard Deviation) 13.01% 55% F 72% C
Risk Adjusted Return 75.74% 76% C+ 85% B
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.